Press Release: Viriom : Viriom to present results of Phase I study of the long acting injectable formulation of novel NNRTi for treatment of HIV-1 infection at CROI 2020

SAN DIEGO, Feb. 17, 2020 /PRNewswire/ --Â Viriom, Inc. will be presenting the results of Phase I study on safety and pharmacology of VM1500-LAI long acting injectable nanoformulation at the Conference on Retroviruses and...